Relevance of neurological assistance in the management of patients with Parkinson’s disease


Дәйексөз келтіру

Толық мәтін

Ашық рұқсат Ашық рұқсат
Рұқсат жабық Рұқсат берілді
Рұқсат жабық Рұқсат ақылы немесе тек жазылушылар үшін

Аннотация

The article presents a review devoted to the relevance of the neurological examination of patients with Parkinson’s disease (PD), as well as the most common causes of error diagnosis of PD, the reasons for hospitalization and mortality in PD.

Толық мәтін

Рұқсат жабық

Авторлар туралы

E. Bril

FSBEIFPE RMACPE of RMH; Federal Neurological Center FMBC n.a. A.I. Burnazyan FMBA of Russia

Email: e.briH@inbox.ru
PhD, Associate Professor of Neurology; Head of the Federal Neurological Center

N. Fedorova

FSBEIFPE RMACPE of RMH

T. Kulua

FSBEIFPE RMACPE of RMH

O. Zimnyakova

Federal Neurological Center FMBC n.a. A.I. Burnazyan FMBA of Russia

M. Anikina

Federal Neurological Center FMBC n.a. A.I. Burnazyan FMBA of Russia

Әдебиет тізімі

  1. Wirdefeldt K., Adami H., Cole P., Trichopoulos D. Epidemiology and etiology of Parkinson's disease: a review of the evidence. J. Eur. J. Epidemiol. 2011;26(Suppl. 1):S1-8.
  2. Левин О.С. Клиническая эпидемиология болезни Паркинсона. В кн.: Болезнь Паркинсона и расстройства движений: рук. для врачей: по матер. II Нац. Конгресса / Под ред. С.Н. Иллариошкина, О.С. Левина. М., 2011. С. 5-9
  3. Neurological disorders. Public health challenges. Chapter 2 Global burden of neurological disorders: estimates and projections. WHO., 2006. P. 27-40.
  4. Левин О.С., Федорова Н.В. Болезнь Паркинсона. 4-е изд. М., 2014. 384 с.
  5. Postuma R., Berg D., Stern M., Poewe W., Olanow C.W., Oertel W., Obeso J., Marek K., Litvan I., Lang A.E., Halliday G., Goetz C.G., Gasser T., Dubois B., Chan P., Bloem B.R., Adler C.H., Deuschl G. MDS Clinical Diagnostic Criteria for Parkinson’s Disease. Mov. Disord. 2015;30(12):1591-601.
  6. Marshall V.L., Reininger C.B., Marquardt M., Patterson J., Hadley D.M., Oertel W.H., Benamer H.T., Kemp P., Burn D., Tolosa E., Kulisevsky J., Cunha L., Costa D., Booij J., Tatsch K., Chaudhuri K.R., Ulm G., Pogarell O., H ffken H., Gerstner A., Grosset D.G. Parkinson’s Disease is overdiagnosed clinically at baseline in diagnostically uncertain cases: a 3-year European Multicenter Study with repeat [123I] FP-CITSPECT. Mov. Disord. 2009;24(4):500-8.
  7. Meara J., Bhowmick B.K., Hobson P Accuracy of diagnosis in patients with presumed Parkinson's disease. Age Ageing. 1999;28:99-102.
  8. Jellinger K. The pathology of parkinsonism. In: Movement Disorders 2. C.D. Marsden, S. Fahn -Butterworth, 1987. P. 124-65.
  9. Schrag A., Ben Shlomo Y., Quinn N. How valid is the clinical diagnosis of Parkinson's disease in the community? J. Neurol. Neurosurg. Psychiatry. 2002;73:529-34.
  10. Кривонос О.В., Смоленцева И.Г., Амосова Н.А. Эпидемиологический мониторинг заболеваемости при болезни Паркинсона. Саратовский научно-медицинский журнал. 2013;9(4):873-77.
  11. Раздорская В.В.,Воскресенская О.Н., Юдина Г.К. Диагностическая надежность амбулаторного звена неврологической помощи пациентам с болезнью Паркинсона. Саратовский научномедицинский журнал. 2012;8(2):513-17.
  12. Willis A.W., Schootman M., Evanoff B.A., Perlmutter J.S. Neurologist care in Parkinson disease. A utilization, outcomes, and survival study Neurology. 2011;77:851-57.
  13. Swarztrauber K., Vickrey B.G. Do neurologists and primary care physicians agree on the extent of specialty involvement of patients referred to neurologists? J. Gen. Intern. Med. 2004;19:654-61.
  14. Bloem B.R., Stocchi F. Move for change part I: a European survey evaluating the impact of the EPDA Charter for People with Parkinson's disease. Eur. J. Neurol. 2012;19:402-10.
  15. Harris-Hayes M., Willis A.W., Klein S.E., Czuppon S. Relative Mortality in U.S. Medicare Beneficiaries with Parkinson Disease and Hip and Pelvic Fractures. J. Bone Joint Surg. Am. 2014;96:e27(1-7).
  16. Safarpour D., Thibault D.P., DeSanto C.L., Boyd C.M., Dorsey E.R., Racette B.A., Willis A.W. Nursing home and end-of-life care in Parkinson disease. Neurology. 2015;85:413-19.
  17. Willis A.W., Schootman M., Tran R., Kung N., Evanoff B.A., Perlmutter J.S., Racette B.A. Neurologist-associated reduction in PD-related hospitalizations and health care expenditures. Neurology. 2012;79:1774-80.
  18. Willis A.W., Schootman M., Kung N., Evanoff B.A., Perlmutter J.S., Racette B.A. Predictors of survival in Parkinson disease. Arch. Neurol. 2012;69(5):601-7.
  19. Clarke C.E. Does levodopa therapy delay death in Parkinson's disease: a review of the evidence. Mov. Disord. 1995;10:250-56.
  20. Clarke C.E. Mortality from Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 2000; 68:254-55.
  21. Poewe W.H., Wenning G.K. The natural history of Parkinson's disease. Ann. Neurol. 1998; 44:S1-9.
  22. de Lau L.M., Breteler M.M. Epidemiology of Parkinson's disease. Lancet Neurol. 2006; 5:525-35.
  23. Diem-Zangerl A.,Seppi K., Wenning G.K., Trinka E., Ransmayr G., Oberaigner W., Poewe W. Mortality in Parkinson's disease: a 20-year follow-up study. Mov. Disord. 2009; 24:819-25.
  24. Rajput A.H., Uitti R.J., Rajput A.H. Timely levodopa (LD) administration prolongs survival in Parkinson's disease. Parkinsonism Relat. Disord. 1997;3:159-65.
  25. Tanner C.M., Goldman S.M. Epidemiology of Parkinson's disease. Neurol. Clin. 1996; 14:317-35.
  26. Marttila R.J., Rinne U.K. Progression and survival in Parkinson's disease. Acta Neurol. Scand. 1991;84:24-8.
  27. Macleod A.D., Taylor K.S., Counsell C.E. Mortality in Parkinson's Disease: A Systematic Review and Meta-analysis. Movement Disorders. 2014;29(13):1615-22.
  28. Jill E., Elaine B., McDade L. Dysphagia and dementia in subjects with Parkinson's disease. Dysphagia. 1995;10(Issue 3):160-64.
  29. Robbins J.A., Logemann J.A., Kirshner H.S. Swallowing and speech production in Parkinson's disease. Ann. Neurol. 1986;19:283-87.
  30. Hely M.A., Morris J.G., Traficante R., Reid W.G., O'Sullivan D.J., Williamson PM. The sydney multicentre study of Parkinson's disease: progression and mortality at 10 years. J. Neurol. Neurosurg. Psychiatry. 1999; 67(3):300-7.
  31. Akbar U., Dham B., He Y., Hack N., Wu S., Troche M., Tighe P., Nelson E., Friedman J., Okun M. Incidence and mortality trends of aspiration pneumonia in Parkinson's disease in the United States, 1979e2010. Parkinsonism. Relat. Disord. 2015;21:1082-86.
  32. Смоленцева И.Г., Чупина Л.П., Кривонос О.В., Амосова Н.А. Причины госпитализаций и смерти при болезни Паркинсона по результатам 3-летнего проспективного исследования. Клиническая неврология. 2013; 2:6-10.

Қосымша файлдар

Қосымша файлдар
Әрекет
1. JATS XML
Жүктеу

© Bionika Media, 2017

Осы сайт cookie-файлдарды пайдаланады

Біздің сайтты пайдалануды жалғастыра отырып, сіз сайттың дұрыс жұмыс істеуін қамтамасыз ететін cookie файлдарын өңдеуге келісім бересіз.< / br>< / br>cookie файлдары туралы< / a>